Lawrence, Kansas – Plastikon Healthcare, LLC is voluntarily recalling one (1) lot of Milk of Magnesia 2400 mg/10 mL Oral Suspension, one (1) lot of Milk of Magnesia 2400 mg/30 mL Oral Suspension, eleven (11) lots of Magnesium Hydroxide 1200 mg/Aluminum Hydroxide 1200 mg/Simethicone 120 mg per 30 mL
Similar Posts
New Clinical Investigation Exclusivity (3-Year Exclusivity) for Drug Products: Questions and Answers
New Clinical Investigation Exclusivity (3-Year Exclusivity) for Drug Products: Questions and AnswersAerosol and Liquid Packaging, Inc. – 676746 – 07/24/2024
CGMP/Finished Pharmaceuticals/AdulteratedContinuous Ventilator Correction: Philips Respironics Updates Use Instructions for BiPAP A30, A40, and V30 Devices Due to Interruptions and/or Loss of Therapy
BiPAP A30, A40, and V30 devices may shut down due to a Ventilator Interruptions, leading to therapy loss. May cause serious injury or death.Coronavirus (COVID-19) Update: Daily Roundup April 13, 2020
Coronavirus (COVID-19) Update: Daily RoundupGenoGenix, LLC. Boca Raton, FL. 483 issued 07/18/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 07/18/2025
Short Title (70 char) GenoGenix, LLC. Boca Raton, FL. 483 issued 07/18/2025
FEI Number 3032144832
Firm Name GenoGenix, LLC
Record Type 483
State FL
Establishment Type Outsourcing FacilityFDA requires expanded labeling about weight loss risk in patients younger than 6 years taking extended-release stimulants for ADHD
The U.S. Food and Drug Administration (FDA) is revising the labeling of all extended-release stimulants indicated to treat attention-deficit/hyperactivity disorder (ADHD) – including certain formulations of amphetamine and methylphenidate – to warn about the risk of weight loss and other adverse rea